Tag Archives: SAGE

Top 10 Medical Stocks To Watch For 2019

Johnny C. Taylor Jr., a human-resources expert, is tackling your questions as part of a series for USA TODAY. Taylor is president and CEO of the Society for Human Resource Management, the world’s largest HR professional society.

The questions submitted by readers and Taylor’s answers below have been edited for length and clarity.

Question: My friend is an Air Force veteran who is now a member of the reserves. She has been trying to get an entry-level IT job at a New York financial firm and has had two final interviews but has not been hired. I believe she was turned down because of discrimination against her reservist status. She trained as a medical technician for 10 years but then used the GI Bill to get her bachelor’s degree in IT from a good school. How do you recommend she address HR questions related to her military service? Are there any recruitment firms that help military members with entry-level jobs where their past skills are not a perfect match? – Tony

Top 10 Medical Stocks To Watch For 2019: Oasis Petroleum Inc.(OAS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    UBS Group AG cut its holdings in Oasis Petroleum Inc. (NYSE:OAS) by 2.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 730,530 shares of the energy producer’s stock after selling 15,269 shares during the quarter. UBS Group AG’s holdings in Oasis Petroleum were worth $5,917,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Oasis Petroleum (OAS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Royal Dutch Shell (NYSE:RDS.A) and Oasis Petroleum (NYSE:OAS) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.

  • [By Stephan Byrd]

    These are some of the media stories that may have impacted Accern Sentiment’s scoring:

    Get Oasis Petroleum alerts:

    Oasis Petroleum CEO: Oil prices always come back to suppl… (finance.yahoo.com) Oasis Petroleum (OAS) Price Target Raised to $17.00 at JPMorgan Chase (americanbankingnews.com) Oasis Petroleum (OAS) Rating Increased to Overweight at Morgan Stanley (americanbankingnews.com) Oasis Petroleum (OAS) Given Buy Rating at Williams Capital (americanbankingnews.com) Oasis Petroleum (OAS) Forecasted to Post FY2018 Earnings of $0.44 Per Share (americanbankingnews.com)

    Several equities research analysts have recently commented on the stock. Stephens set a $15.00 price target on shares of Oasis Petroleum and gave the stock a “buy” rating in a research report on Tuesday, April 24th. Williams Capital reiterated a “buy” rating and set a $18.00 price target on shares of Oasis Petroleum in a research report on Wednesday. JPMorgan Chase & Co. set a $17.00 price target on shares of Oasis Petroleum and gave the stock a “buy” rating in a research report on Wednesday. Morgan Stanley upgraded shares of Oasis Petroleum from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $12.52 to $19.00 in a research report on Wednesday. Finally, BMO Capital Markets lifted their price target on shares of Oasis Petroleum from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, May 1st. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and sixteen have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $12.41.

  • [By Matthew DiLallo]

    Shares of Oasis Petroleum Inc. (NYSE:OAS) rallied 13.2% in August, primarily due to the oil driller’s stronger-than-expected second-quarter report.

  • [By Matthew DiLallo]

    Oasis Midstream Partners is also an MLP created by an oil company, though its parent, Oasis Petroleum (NYSE:OAS), isn’t quite as well known as the other two. It’s also new to the market since it just went public last year. However, it does have two things that set it apart.

Top 10 Medical Stocks To Watch For 2019: Alaska Air Group, Inc.(ALK)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Grubhub (GRUB) , Sprint (S) , LG Homes (LGIH) , Acadia Pharmaceuticals (ACAD) , Pilgrim’s Pride (PPC) , Opko Health (OPK) , Alaska Air Group (ALK) and Winnebago Industries (WGO) .

  • [By Lee Jackson]

    This company has a big west coast exposure and continues to rank high on Wall Street. Alaska Air Group Inc. (NYSE: ALK) is the parent company of Alaska Airlines, and it reported impressive traffic data buoyed by strong demand. The company serves more than 100 cities through an expansive network in Alaska, the Lower 48 states, Hawaii, Canada and Mexico. Despite recent challenges by other carriers for superiority in the Northwest, the company has strong customer loyalty, which has contributed to outstanding earnings and revenue growth.

  • [By ]

    Alaska Air Group (ALK) : “It used to be the best before the acquisition and now it’s not great and I can’t recommend it anymore.”

    Winnebago Industries (WGO) : “This group trades badly. All we hear about is an inventory glut. We need someone to tell us otherwise.”

  • [By Adam Levine-Weinberg]

    Southwest still needs to get FAA approval before it can begin ticket sales, but on Thursday, it offered more details of its plans for Hawaii. Based on Southwest’s service proposal, Alaska Air (NYSE:ALK) could be forced to significantly scale back its presence in the Hawaii market.

  • [By Adam Levine-Weinberg]

    Alaska Air’s (NYSE:ALK) dismal earnings trend continued last week, as it posted a sharp drop in profit for the second quarter. So far, the third quarter is shaping up to be just as bad. Alaska Airlines’ guidance implies another big profit decline.

  • [By Adam Levine-Weinberg]

    The last couple of years have not been kind to JetBlue Airways (NASDAQ:JBLU) and Alaska Air Group (NYSE:ALK). Rising fuel prices have pinched profitability across the U.S. airline industry, but due to competitive dynamics and other factors, JetBlue and Alaska have had more trouble offsetting these cost headwinds than some other carriers.

Top 10 Medical Stocks To Watch For 2019: HSBC Holdings PLC (HSBA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    HSBC (LON:HSBA) had its price target dropped by equities research analysts at Citigroup from GBX 810 ($10.78) to GBX 800 ($10.65) in a report released on Tuesday. The brokerage currently has a “buy” rating on the financial services provider’s stock. Citigroup’s price target points to a potential upside of 9.59% from the stock’s previous close.

  • [By Joseph Griffin]

    HSBC (LON:HSBA) had its target price lowered by equities research analysts at Shore Capital from GBX 721 ($9.60) to GBX 625 ($8.32) in a report issued on Tuesday. The brokerage presently has a “sell” rating on the financial services provider’s stock. Shore Capital’s price objective indicates a potential downside of 14.71% from the company’s previous close.

  • [By Max Byerly]

    Credit Suisse Group set a GBX 720 ($9.32) price target on HSBC (LON:HSBA) in a research report sent to investors on Tuesday morning. The firm currently has a neutral rating on the financial services provider’s stock.

  • [By Max Byerly]

    HSBC Holdings plc (LON:HSBA) has received an average recommendation of “Hold” from the sixteen analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is GBX 768.33 ($9.80).

Top 10 Medical Stocks To Watch For 2019: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect PetroChina (PTR) Stock Price” was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at www.tickerreport.com/banking-finance/3368551/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-petrochina-ptr-stock-price.html.

  • [By Ethan Ryder]

    PetroChina (NYSE: PTR) and Callitas Health (OTCMKTS:MPHMF) are both oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.

  • [By Max Byerly]

    Gabelli Funds LLC lessened its holdings in shares of PetroChina Company Limited (NYSE:PTR) by 34.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,800 shares of the oil and gas company’s stock after selling 2,000 shares during the quarter. Gabelli Funds LLC’s holdings in PetroChina were worth $290,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Medical Stocks To Watch For 2019: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Stevens Capital Management LP bought a new stake in shares of SAGE Therapeutics Inc (NASDAQ:SAGE) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,223 shares of the biopharmaceutical company’s stock, valued at approximately $504,000.

  • [By Maxx Chatsko]

    After sliding 41.8% in 2018, shares of Sage Therapeutics (NASDAQ:SAGE) jumped nearly 49% last month, according to data from S&P Global Market Intelligence. The sudden leap came after the company reported impressive results for SAGE-217 in a phase 3 trial studying the drug candidate as a potential treatment for postpartum depression.

  • [By Dan Caplinger]

    Tuesday saw a mixed session on Wall Street, with various market benchmarks moving in different directions. Investors seemed reasonably neutral about events in Singapore, where leaders from the U.S. and North Korea met and came to some minor agreements that viewed in the most favorable light could provide a road map for future negotiations. Yet investors seem more concerned about what the Federal Reserve’s interest rate setting board might do later in the week, with a two-day meeting starting today to consider whether further rate increases are warranted. Even with the relatively flat performance from the market, some companies had good news that sent their shares sharply higher. Tesla (NASDAQ:TSLA), Sage Therapeutics (NASDAQ:SAGE), and Lands’ End (NASDAQ:LE) were among the best performers on the day. Here’s why they did so well.

  • [By Shane Hupp]

    SG Americas Securities LLC acquired a new position in SAGE Therapeutics Inc (NASDAQ:SAGE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,233 shares of the biopharmaceutical company’s stock, valued at approximately $843,000.

  • [By Chris Lange]

    Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S. Food and Drug Administration (FDA).

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top 10 Medical Stocks To Watch For 2019: Aethlon Medical, Inc.(AEMD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Aethlon Medical (AEMD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Aethlon Medical (NASDAQ: AEMD) is one of 23 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Aethlon Medical to related businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.

  • [By Max Byerly]

    Aethlon Medical (NASDAQ: AEMD) is one of 23 public companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Aethlon Medical to related businesses based on the strength of its profitability, valuation, analyst recommendations, earnings, risk, dividends and institutional ownership.

Top 10 Medical Stocks To Watch For 2019: Approach Resources Inc.(AREX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Approach Resources Inc. (NASDAQ:AREX) hit a new 52-week low during trading on Thursday . The company traded as low as $2.02 and last traded at $2.04, with a volume of 2875 shares trading hands. The stock had previously closed at $2.08.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Media headlines about Approach Resources (NASDAQ:AREX) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Approach Resources earned a coverage optimism score of 0.02 on Accern’s scale. Accern also gave press coverage about the energy company an impact score of 46.8987147373518 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Joseph Griffin]

    Shares of Approach Resources Inc. (NASDAQ:AREX) have received an average recommendation of “Hold” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $2.75.

Top 10 Medical Stocks To Watch For 2019: Diageo plc(DEO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    MUFG Americas Holdings Corp lowered its holdings in Diageo plc (NYSE:DEO) by 6.6% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,465 shares of the company’s stock after selling 595 shares during the quarter. MUFG Americas Holdings Corp’s holdings in Diageo were worth $1,219,000 as of its most recent filing with the SEC.

  • [By Jeremy Bowman]

    Diageo (NYSE:DEO), the global alcohol giant that owns Guinness beer and Smirnoff vodka, has held discussions with at least three marijuana growers, though it has yet to make a deal, and Heineken’s (NASDAQOTH:HEINY) Lagunitas brand launched a THC-infused beverage back in June, which is currently available in California dispensaries. 

  • [By Keith Speights]

    There’s another Canadian marijuana market that won’t open for business in October in which investors appear to be hoping Tilray will be a major contender. Cannabis edibles (including cannabis-infused beverages) and concentrates won’t be allowed until next year. Large British alcoholic beverage maker Diageo plc (NYSE:DEO) is reportedly looking for a cannabis partner to target this market. Tilray could be one of Diageo’s top candidates.

  • [By Logan Wallace]

    Media headlines about Diageo (NYSE:DEO) have trended somewhat positive this week, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Diageo earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.680770361691 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Stephen Mack]

    Aside from major corporations like The Hershey Co. (NYSE: HSY) and Diageo Plc. (NYSE: DEO), ServiceNow clients include giant institutions such as CERN, the European physics lab that employs 12,000 scientists, and New York City’s 6,000-employee Department of Health.

  • [By Keith Speights]

    BNN Bloomberg reported late last week that U.K.-based beverage company Diageo plc (NYSE:DEO), the maker of Guinness beer and Smirnoff vodka, has been in talks with at least three Canadian marijuana growers. No firm details are available at this point. However, several stocks of cannabis producers have soared on speculation that they could be the next to snag a deal.

Top 10 Medical Stocks To Watch For 2019: TD Ameritrade Holding Corporation(AMTD)

Advisors’ Opinion:

  • [By ]

    TD Ameritrade Holding Corp. (AMTD) has made crypto history as the first firm ever to place an advertisement on the blockchain. “Through a series of transactions we became the first brand to place an ad in the blockchain. Why? Well, we love finding new ways to use emerging technology. So we decided to have a little fun and plant our flag,” TD wrote on its website, where it included a photo of the ad embedded right into the blockchain code. The process took 68 transactions and TD used the OP_Return feature in bitcoin’s protocol to insert characters as one might write a memo on a check. The resulting transactions were invalid, but they remain preserved on the blockchain ledger for as long as it exists.

  • [By Jon C. Ogg]

    TD Ameritrade Holding Corp. (NASDAQ: AMTD) is the second largest discount and online broker by market value, with a $32 billion market cap. Its shares were down almost 6% at $56.65 after the JPMorgan news. TD Ameritrade has a consensus price target of $68.32 and a 52-week range of $42.14 to $63.01.

  • [By Logan Wallace]

    TD Ameritrade (NASDAQ:AMTD) announced a quarterly dividend on Monday, April 23rd, RTT News reports. Shareholders of record on Tuesday, May 8th will be paid a dividend of 0.21 per share by the financial services provider on Tuesday, May 22nd. This represents a $0.84 annualized dividend and a yield of 1.42%. The ex-dividend date is Monday, May 7th.

Top 10 Medical Stocks To Watch For 2019: Transmontaigne Partners L.P.(TLP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on TransMontaigne Partners (TLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Shares of TransMontaigne Partners L.P. (NYSE:TLP) have received a consensus recommendation of “Hold” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $40.75.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TransMontaigne Partners (TLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TransMontaigne Partners (TLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top High Tech Stocks To Watch Right Now

U.K. stocks finished higher Wednesday, reversing course as gains for shares of Lloyds Banking Group PLC and Glencore PLC, which released financial updates, accelerated during the session.

Stocks in London overcame the losing tone set early by U.S. stocks, which snapped a win streak in the previous session. Meanwhile, the pound was whipped around after economic data and parliamentary testimony by Bank of England policy makers.

Top High Tech Stocks To Watch Right Now: Summit State Bank(SSBI)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine upgraded shares of Summit State Bank (NASDAQ:SSBI) from a hold rating to a buy rating in a research note released on Saturday.

    Separately, TheStreet raised Summit State Bank from a c+ rating to a b rating in a report on Wednesday, February 14th.

Top High Tech Stocks To Watch Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By Maxx Chatsko]

    Shares of Sage Therapeutics (NASDAQ:SAGE) soared more than 20% today after the company announced that the U.S. Food and Drug Administration will allow an expedited development program for one of its most promising drug candidates.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SAGE Therapeutics (SAGE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S. Food and Drug Administration (FDA).

Top High Tech Stocks To Watch Right Now: National Health Investors, Inc.(NHI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of National Health Investors, Inc. (NYSE:NHI) have received a consensus rating of “Hold” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $71.43.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Virginia Retirement Systems ET AL lifted its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,300 shares of the real estate investment trust’s stock after acquiring an additional 10,700 shares during the period. Virginia Retirement Systems ET AL owned approximately 0.28% of National Health Investors worth $7,826,000 as of its most recent filing with the Securities & Exchange Commission.

Top High Tech Stocks To Watch Right Now: Matrix Service Company(MTRX)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Matrix Service (NASDAQ:MTRX) Q4 2018 Earnings Conference CallSep. 11, 2018 10:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Matrix Service Co (NASDAQ:MTRX) CEO John R. Hewitt sold 17,816 shares of the firm’s stock in a transaction dated Wednesday, June 13th. The shares were sold at an average price of $19.25, for a total transaction of $342,958.00. Following the transaction, the chief executive officer now directly owns 261,213 shares in the company, valued at approximately $5,028,350.25. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

  • [By Ethan Ryder]

    Matrix Service (NASDAQ:MTRX) issued an update on its FY19 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $0.85-1.15 for the period, compared to the Thomson Reuters consensus estimate of $0.94. The company issued revenue guidance of $1.25-1.35 billion, compared to the consensus revenue estimate of $1.25 billion.

  • [By Logan Wallace]

    Trexquant Investment LP bought a new position in shares of Matrix Service Co (NASDAQ:MTRX) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 16,350 shares of the oil and gas company’s stock, valued at approximately $224,000. Trexquant Investment LP owned 0.06% of Matrix Service as of its most recent filing with the SEC.

Top 5 Undervalued Stocks To Buy Right Now

Below is my list of the top gold & silver mining stock takeover targets. None of them are producers, but they all have very lucrative properties. Plus, they are all undervalued. Most of them have very advanced projects.

Stock Name

Symbol (US)

Type

Share Price (US)

FD Shares

FD Mkt Cap (4/3/2017)

Alexco Resources

AXU

Silver

$1.52

108M

$164M

Aurvista Gold

ARVSF

Gold

$0.22

200M

$45M

Barkerville Gold Mining

Top 5 Undervalued Stocks To Buy Right Now: Turkcell Iletisim Hizmetleri AS(TKC)

Advisors’ Opinion:

  • [By Rich Smith]

    Shares of Turkish telecom Turkcell Iletisim Hizmetleri (NYSE:TKC) plummeted 10% to close at $4.42 per share on Thursday — then proceeded to slide more after-hours. Perhaps worse for investors trying to figure out how to react to this news: There was no obvious reason for the decline.

  • [By Dan Caplinger]

    The stock market lost ground on Monday, although the declines in some major benchmarks were more extreme than others. A budding financial crisis in Turkey once again captured the attention of investors, as the threat of rising tariffs and escalating diplomatic tension could drive a wedge through the North Atlantic Treaty Organization at a critical time for the geopolitical environment in the region. The repercussions of recent events involving Turkey echoed around the world, and some companies felt the tremors more sharply than others. First Majestic Silver (NYSE:AG), Turkcell Iletisim Hizmetleri (NYSE:TKC), and Transocean (NYSE:RIG) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Rich Smith]

    Turkish telco Turkcell Iletisim Hizmetleri (NYSE:TKC) became the latest victim of President Donald Trump’s favorite foreign policy tool — the tariff — this morning, falling 13.1% (as of 11:40 a.m. EDT) after the United States announced it would double the amount of tariffs imposed on steel and aluminum imported to the U.S. from Turkey.

  • [By Rich Smith]

    Turkish telco Turkcell Iletisim Hizmetleri (NYSE:TKC) closed up 11.6% on Thursday after the country’s central bank announced a big boost to interest rates — 24%, or 6.25 percentage points more than previously — boosting the Turkish lira’s value against the U.S. dollar for the third straight day.

Top 5 Undervalued Stocks To Buy Right Now: Apartment Investment and Management Company(AIV)

Advisors’ Opinion:

  • [By Max Byerly]

    Apartment Investment and Management (NYSE:AIV) had its hold rating reiterated by analysts at BMO Capital Markets. They currently have a $47.00 price target on the stock.

  • [By Stephan Byrd]

    News headlines about Apartment Investment and Management (NYSE:AIV) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Apartment Investment and Management earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 46.6669103193152 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

  • [By Ethan Ryder]

    Apartment Investment and Management (NYSE:AIV)‘s stock had its “hold” rating reiterated by equities researchers at BMO Capital Markets in a research report issued on Thursday. They currently have a $44.00 price target on the real estate investment trust’s stock. BMO Capital Markets’ price target suggests a potential upside of 3.92% from the company’s current price.

  • [By Max Byerly]

    Bank of Montreal Can increased its position in shares of Apartment Investment and Management Co (NYSE:AIV) by 91.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 184,796 shares of the real estate investment trust’s stock after buying an additional 88,340 shares during the period. Bank of Montreal Can owned about 0.12% of Apartment Investment and Management worth $7,818,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Apartment Investment and Management (AIV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Buy Right Now: Attunity Ltd.(ATTU)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Attunity Ltd (NASDAQ:ATTU) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $12.33.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Buy Right Now: Petroleum Resources Corporation(PEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Adams Natural Resources Fund (NYSE:PEO) has trended somewhat negative recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Adams Natural Resources Fund earned a coverage optimism score of -0.09 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 48.0521373671292 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 5 Undervalued Stocks To Buy Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Shane Hupp]

    SG Americas Securities LLC acquired a new position in SAGE Therapeutics Inc (NASDAQ:SAGE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,233 shares of the biopharmaceutical company’s stock, valued at approximately $843,000.

  • [By Maxx Chatsko]

    Shares of Sage Therapeutics (NASDAQ:SAGE) soared more than 20% today after the company announced that the U.S. Food and Drug Administration will allow an expedited development program for one of its most promising drug candidates.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Joseph Griffin]

    Stevens Capital Management LP bought a new stake in shares of SAGE Therapeutics Inc (NASDAQ:SAGE) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,223 shares of the biopharmaceutical company’s stock, valued at approximately $504,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SAGE Therapeutics (SAGE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks For 2019

Three minutes of frantic trading in Treasuries futures just offered a stark reminder of the danger of betting against the world’s safest asset.

What was shaping up as a second straight day of losses in Treasuries on Thursday, with 10-year yields threatening to hit the key psychological level of 3 percent, turned around in a hurry as turmoil in emerging markets spooked global investors.

Traders pointed to Brazilian officials’ unsuccessful efforts to stem the free-fall in their currency as the trigger for the wave of Treasuries buying. But the rush was magnified because investors were caught offside — there had been a dramatic increase in short bets against U.S. government debt in the past week.

The abruptness of the move, which drove yields on benchmark 10-year notes plunging as much as 9 basis points to 2.88 percent, was apparent in the futures market: From 1:33 p.m. New York time to 1:36 p.m., more than 100,000 contracts on 10-year futures changed hands. To put that in context, that’s more than the 80,000 that traded over a similar span at the time of Friday’s release of U.S. labor data.

Top 10 Safest Stocks For 2019: Celadon Group, Inc.(CGI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Scopus Asset Management L.P. reduced its holdings in shares of Celadon Group, Inc. (NYSE:CGI) by 57.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 900,000 shares of the transportation company’s stock after selling 1,218,285 shares during the quarter. Scopus Asset Management L.P. owned approximately 3.18% of Celadon Group worth $3,330,000 as of its most recent filing with the SEC.

  • [By Stephan Byrd]

    Russell Investments Group Ltd. boosted its position in shares of Celadon Group, Inc. (NYSE:CGI) by 26.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,347,089 shares of the transportation company’s stock after purchasing an additional 283,476 shares during the quarter. Russell Investments Group Ltd. owned about 4.76% of Celadon Group worth $4,983,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Safest Stocks For 2019: Foamix Pharmaceuticals Ltd.(FOMX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Press coverage about Foamix Pharmaceuticals (NASDAQ:FOMX) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.14 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 45.4298608245084 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 10 Safest Stocks For 2019: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION(SAIC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Science Applications International (SAIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Science Applications International Corporation (NYSE:SAIC)Q1 2019 Earnings Conference CallJune 12, 2018, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lou Whiteman]

    The Marine Corps has selected BAE Systems (NASDAQOTH:BAESY) to manufacture its next-generation amphibious combat vehicle, dealing a major setback to the diversification plans of Science Applications International (NYSE:SAIC).

  • [By Garrett Baldwin]

    Today, Bill offers our readers a few of his favorites as Trump meets with Kim Jong Un.Here’s how to cash in regardless of how this summit turns out in the long run.

    The Top Stock Market Stories for Tuesday
    Last night, President Trump met North Korean leader Kim Jong Un in Singapore. This was the first meeting between a sitting American president and a North Korean leader. Following the agreement, analysts noted that the document signed by both parties included no concrete details for achieving denuclearization on the Korean Peninsula. Trump responded to criticism by saying he is fully confident that the Korean dictatorship will follow through. A U.S. district court will rule on whether to approve an $85 billion merger between AT&T Inc. (NYSE: T) and Time Warner Inc. (NYSE: TWX). The decision comes after about six weeks of debate in a courtroom. The ruling will likely have a significant impact on the proposed bid by The Walt Disney Co. (NYSE: DIS) for media giant Twenty-First Century Fox Inc.(NYSE: FOXA). The Fed Open Market Committee kicks off its June meeting today. The U.S. central bank is expected to raise interest rates for the second time in 2018. On Wednesday, U.S. Federal Reserve Chair Jerome Powell will likely announce a hike of 0.25% to the benchmark rate to 2%. This would also mark the seventh hike since December 2015. Markets will be looking for clues during Powell’s conference to determine how many additional times the Fed plans to raise interest rates during the final six months of the year.
    Three Stocks to Watch Today: RH, TSLA, GE
    Restoration Hardware Holdings Inc. (NYSE: RH) stock popped more than 20% in pre-market hours after the company reported very strong profits for the quarter. The retailer reported earnings per share of $1.33, well above the $1.02 anticipated by analysts. The company also reported a strong second-quarter outlook, news that reduced concerns about it falling short of revenue expectations. Tesla Inc. (Nasdaq: TS

  • [By Rich Smith]

    Investors in Science Applications International Corporation (NYSE:SAIC) had a bad week last week: Its stock plunged 8% in a single day after it reported earnings — and ended the week even lower. SAIC shares are clawing back some losses this week — but do they deserve to?

  • [By Rich Smith]

    Let’s start with the story that sparked the rally. Last night, Reuters cited three sources “familiar with the matter” saying that Engility “is exploring a sale” — perhaps to CACI International (NYSE:CACI) or Science Applications International Corp (NYSE:SAIC), two peer defense contractors that are both three to four times larger than Engility.

Top 10 Safest Stocks For 2019: Monmouth Real Estate Investment Corporation(MNR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Monmouth Real Estate Investment (MNR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Schwab Charles Investment Management Inc. boosted its holdings in shares of Monmouth R.E. Inv. Corp. Class A (NYSE:MNR) by 8.6% during the 1st quarter, HoldingsChannel reports. The fund owned 372,649 shares of the real estate investment trust’s stock after purchasing an additional 29,526 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Monmouth R.E. Inv. Corp. Class A were worth $5,605,000 as of its most recent SEC filing.

Top 10 Safest Stocks For 2019: W&T Offshore Inc.(WTI)

Advisors’ Opinion:

  • [By Logan Wallace]

    W&T Offshore, Inc. (NYSE:WTI) gapped down before the market opened on Tuesday . The stock had previously closed at $7.89, but opened at $7.87. W&T Offshore shares last traded at $8.23, with a volume of 68640 shares.

  • [By Stephan Byrd]

    W&T Offshore (NYSE:WTI) last issued its quarterly earnings data on Wednesday, May 2nd. The oil and gas company reported $0.19 EPS for the quarter, hitting analysts’ consensus estimates of $0.19. The firm had revenue of $134.20 million during the quarter, compared to analyst estimates of $137.80 million. W&T Offshore had a negative return on equity of 15.43% and a net margin of 16.71%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.16 EPS. equities analysts forecast that W&T Offshore, Inc. will post 0.66 earnings per share for the current year.

  • [By Stephan Byrd]

    Shares of W&T Offshore, Inc. (NYSE:WTI) rose 8.3% during mid-day trading on Friday . The stock traded as high as $7.48 and last traded at $7.47. Approximately 3,521,727 shares were traded during mid-day trading, an increase of 12% from the average daily volume of 3,143,397 shares. The stock had previously closed at $6.90.

  • [By Shane Hupp]

    Weatherly International plc (LON:WTI) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 0.09 ($0.00) and last traded at GBX 0.19 ($0.00), with a volume of 58655113 shares. The stock had previously closed at GBX 0.19 ($0.00).

Top 10 Safest Stocks For 2019: Sealed Air Corporation(SEE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Sealed Air (NYSE:SEE) has been given a $52.00 target price by investment analysts at UBS in a research report issued to clients and investors on Wednesday, www.stocktargetadvisor.com reports. The brokerage presently has a “buy” rating on the industrial products company’s stock. UBS’s price objective indicates a potential upside of 13.99% from the stock’s current price.

  • [By Max Byerly]

    State of New Jersey Common Pension Fund D lessened its holdings in shares of Sealed Air (NYSE:SEE) by 16.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 50,000 shares of the industrial products company’s stock after selling 10,000 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Sealed Air were worth $2,140,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Sealed Air (SEE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of Seeing Machines Limited (LON:SEE) rose 17.3% during mid-day trading on Tuesday . The stock traded as high as GBX 9.70 ($0.13) and last traded at GBX 9.15 ($0.12). Approximately 28,492,209 shares traded hands during mid-day trading, an increase of 461% from the average daily volume of 5,080,000 shares. The stock had previously closed at GBX 7.80 ($0.10).

  • [By Shane Hupp]

    Celanese (NYSE: CE) and Sealed Air (NYSE:SEE) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Top 10 Safest Stocks For 2019: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    However, after announcing the sale of its interest in EnLink Midstream Partners (NYSE: ENLK) and EnLink Midstream (NYSE: ENLC) for $3.125 billion in June, it boosted its buyback authorization up to $4 billion. That represents enough cash to retire roughly 20% of its outstanding shares. Devon expects the sale of EnLink to close this July, which will enable it to accelerate the pace of repurchases through the end of 2019.

  • [By Joseph Griffin]

    ValuEngine upgraded shares of EnLink Midstream Partners (NYSE:ENLK) from a strong sell rating to a sell rating in a research report released on Thursday morning.

  • [By Matthew DiLallo]

    The company took a major step in that direction this week after announcing that it had agreed to sell its stakes in midstream companies EnLink Midstream Partners (NYSE:ENLK) and EnLink Midstream (NYSE:ENLC) for $3.125 billion in cash. The shale driller plans to use that cash to repurchase up to $4 billion of its shares through the end of next year, assuming this transaction closes. These moves could unlock significant shareholder value in the coming year.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on EnLink Midstream Partners (ENLK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks For 2019: Watsco, Inc.(WSO.B)

Advisors’ Opinion:

  • [By Shane Hupp]

    Watsco Inc Class B (NYSE:WSO.B) declared a quarterly dividend on Monday, July 2nd, NASDAQ reports. Stockholders of record on Tuesday, July 17th will be given a dividend of 1.45 per share by the construction company on Tuesday, July 31st. This represents a $5.80 annualized dividend and a dividend yield of 3.28%. The ex-dividend date of this dividend is Monday, July 16th.

Top 10 Safest Stocks For 2019: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Sage Therapeutics (NASDAQ:SAGE) soared more than 20% today after the company announced that the U.S. Food and Drug Administration will allow an expedited development program for one of its most promising drug candidates.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SAGE Therapeutics (SAGE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By Dan Caplinger]

    Tuesday saw a mixed session on Wall Street, with various market benchmarks moving in different directions. Investors seemed reasonably neutral about events in Singapore, where leaders from the U.S. and North Korea met and came to some minor agreements that viewed in the most favorable light could provide a road map for future negotiations. Yet investors seem more concerned about what the Federal Reserve’s interest rate setting board might do later in the week, with a two-day meeting starting today to consider whether further rate increases are warranted. Even with the relatively flat performance from the market, some companies had good news that sent their shares sharply higher. Tesla (NASDAQ:TSLA), Sage Therapeutics (NASDAQ:SAGE), and Lands’ End (NASDAQ:LE) were among the best performers on the day. Here’s why they did so well.

Top 10 Safest Stocks For 2019: Schweitzer-Mauduit International Inc.(SWM)

Advisors’ Opinion:

Top 5 Undervalued Stocks For 2019

CCUR Holdings, Inc. (NASDAQ:CCUR) major shareholder Julian D. Singer bought 2,175 shares of the company’s stock in a transaction that occurred on Monday, June 18th. The shares were bought at an average cost of $5.31 per share, for a total transaction of $11,549.25. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

CCUR traded down $0.45, hitting $4.85, during midday trading on Tuesday, Marketbeat.com reports. CCUR Holdings, Inc. has a 12 month low of $4.62 and a 12 month high of $6.95.

Get CCUR alerts:

CCUR announced that its board has approved a stock repurchase program on Monday, March 5th that authorizes the company to buyback 1,000,000 outstanding shares. This buyback authorization authorizes the technology company to purchase shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Top 5 Undervalued Stocks For 2019: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Shane Hupp]

    SG Americas Securities LLC acquired a new position in SAGE Therapeutics Inc (NASDAQ:SAGE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,233 shares of the biopharmaceutical company’s stock, valued at approximately $843,000.

  • [By Maxx Chatsko]

    Shares of Sage Therapeutics (NASDAQ:SAGE) soared more than 20% today after the company announced that the U.S. Food and Drug Administration will allow an expedited development program for one of its most promising drug candidates.

  • [By Dan Caplinger]

    Tuesday saw a mixed session on Wall Street, with various market benchmarks moving in different directions. Investors seemed reasonably neutral about events in Singapore, where leaders from the U.S. and North Korea met and came to some minor agreements that viewed in the most favorable light could provide a road map for future negotiations. Yet investors seem more concerned about what the Federal Reserve’s interest rate setting board might do later in the week, with a two-day meeting starting today to consider whether further rate increases are warranted. Even with the relatively flat performance from the market, some companies had good news that sent their shares sharply higher. Tesla (NASDAQ:TSLA), Sage Therapeutics (NASDAQ:SAGE), and Lands’ End (NASDAQ:LE) were among the best performers on the day. Here’s why they did so well.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

Top 5 Undervalued Stocks For 2019: Two River Bancorp(TRCB)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Two Rivers Bancorp (NASDAQ:TRCB) have trended somewhat positive recently, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Two Rivers Bancorp earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.3815117771449 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 5 Undervalued Stocks For 2019: iShares Global Infrastructure (IGF)

Advisors’ Opinion:

  • [By Sarah Priestley]

    And if you are an investor who prefers ETFs and mutual funds, there are a couple of options for you: iShares Global Infrastructure ETF(NASDAQ:IGF), andLazard Global Listed Infrastructure(NASDAQMUTFUND:GLIFX). I would caution anybody tocheck the percentage of utilities that are within these baskets, just to check theutilities exposure. But, generally, not bad options to check out.

Top 5 Undervalued Stocks For 2019: Matrix Service Company(MTRX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Matrix Service Co (NASDAQ:MTRX) CEO John R. Hewitt sold 17,816 shares of the firm’s stock in a transaction dated Wednesday, June 13th. The shares were sold at an average price of $19.25, for a total transaction of $342,958.00. Following the transaction, the chief executive officer now directly owns 261,213 shares in the company, valued at approximately $5,028,350.25. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

  • [By Logan Wallace]

    Trexquant Investment LP bought a new position in shares of Matrix Service Co (NASDAQ:MTRX) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 16,350 shares of the oil and gas company’s stock, valued at approximately $224,000. Trexquant Investment LP owned 0.06% of Matrix Service as of its most recent filing with the SEC.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Booking Holdings Inc. (NASDAQ: BKNG) is projected to post quarterly earnings at $10.67 per share on revenue of $2.87 billion.
    CenturyLink, Inc. (NYSE: CTL) is expected to post quarterly earnings at $0.19 per share on revenue of $6.00 billion.
    Albemarle Corporation (NYSE: ALB) is projected to post quarterly earnings at $1.21 per share on revenue of $803.36 million.
    Spectra Energy Partners, LP (NYSE: SEP) is estimated to post quarterly earnings at $0.81 per share on revenue of $751.57 million.
    IAC/InterActiveCorp (NASDAQ: IAC) is expected to post quarterly earnings at $0.8 per share on revenue of $923.80 million.
    Open Text Corporation (NASDAQ: OTEX) is projected to post quarterly earnings at $0.62 per share on revenue of $691.75 million.
    Tutor Perini Corporation (NYSE: TPC) is expected to post quarterly earnings at $0.29 per share on revenue of $1.09 billion.
    Twenty-First Century Fox, Inc. (NASDAQ: FOXA) is projected to post quarterly earnings at $0.54 per share on revenue of $7.41 billion.
    ICU Medical, Inc. (NASDAQ: ICUI) is estimated to post quarterly earnings at $1.84 per share on revenue of $346.28 million.
    TechnipFMC plc (NYSE: FTI) is expected to post quarterly earnings at $0.33 per share on revenue of $3.13 billion.
    Synaptics Incorporated (NASDAQ: SYNA) is projected to post quarterly earnings at $0.91 per share on revenue of $401.76 million.
    The Dun & Bradstreet Corporation (NYSE: DNB) is expected to post quarterly earnings at $1.07 per share on revenue of $386.91 million.
    Matrix Service Company (NASDAQ: MTRX) is estimated to post quarterly earnings at $0.07 per share on revenue of $285.16 million.
    Maiden Holdings, Ltd. (NASDAQ: MHLD) is projected to post quarterly earnings at $0.21 per share on revenue of $739.31 million.
    tronc, Inc. (NASDAQ: TRNC) is expected to post quarterly earnings at $0.65 per share on revenue of $428.25 million.
    Copa Holdings,

  • [By Joseph Griffin]

    Matrix Service (NASDAQ:MTRX) – Stock analysts at KeyCorp decreased their FY2018 EPS estimates for shares of Matrix Service in a research report issued to clients and investors on Tuesday, May 15th. KeyCorp analyst T. Afzal now expects that the oil and gas company will post earnings of $0.23 per share for the year, down from their previous forecast of $0.65. KeyCorp also issued estimates for Matrix Service’s Q4 2018 earnings at $0.07 EPS.

  • [By Max Byerly]

    Matrix Service Co (NASDAQ:MTRX) insider James P. Ryan sold 2,774 shares of the firm’s stock in a transaction on Wednesday, June 13th. The shares were sold at an average price of $18.95, for a total value of $52,567.30. Following the sale, the insider now directly owns 70,290 shares of the company’s stock, valued at $1,331,995.50. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Top 5 Undervalued Stocks For 2019: SL Green Realty Corporation(SLG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Easterly Government Properties (NYSE: DEA) and SL Green Realty (NYSE:SLG) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SL Green Realty (SLG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of SL Green Realty Corp (NYSE:SLG) have been given an average recommendation of “Hold” by the eighteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, six have given a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $111.54.

  • [By Max Byerly]

    Sterlingcoin (SLG) is a proof-of-stake (PoS) coin that uses the
    X13 hashing algorithm. It was first traded on September 21st, 2014. Sterlingcoin’s total supply is 4,241,006 coins. Sterlingcoin’s official Twitter account is @SterlingcoinSLG and its Facebook page is accessible here. The Reddit community for Sterlingcoin is /r/sterlingcoin and the currency’s Github account can be viewed here. The official website for Sterlingcoin is sterlingcoin.org.

  • [By Joseph Griffin]

    Swiss National Bank lessened its stake in SL Green Realty (NYSE:SLG) by 13.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 315,900 shares of the real estate investment trust’s stock after selling 51,200 shares during the period. Swiss National Bank owned 0.35% of SL Green Realty worth $30,589,000 as of its most recent SEC filing.

Hot Medical Stocks To Invest In 2019

Planning for retirement generally means taking a close look at your personal needs and goals, as well as those of the person you’re married to. But when you and your spouse have a wide age gap, retirement planning can become a bit trickier. Not only are you less likely, in that scenario, to retire simultaneously, but there may also be consequences to one of you leaving the workforce well ahead of the other. Therefore, be sure to consider the following factors when you’re dealing with a significant age gap.

1. Health insurance

Medicare eligibility begins at age 65, so if you retire then and give up your group health plan at work, you’ll have coverage right away. But if your spouse gets his or her health insurance through you and your employer, and he or she is not yet eligible for Medicare, you’ll need to collectively figure out what to do about medical coverage. Though you can obtain insurance through COBRA, the cost can be prohibitive, and your maximum coverage period is generally 18 months. Buying insurance on the open market is also an option, but you might find yourself spending quite a substantial amount of money for coverage that’s mediocre at best.

Hot Medical Stocks To Invest In 2019: Jason Industries, Inc.(JASN)

Advisors’ Opinion:

  • [By Shane Hupp]

    PlayAGS (NYSE: AGS) and Jason Industries (NASDAQ:JASN) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership.

Hot Medical Stocks To Invest In 2019: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Sage Therapeutics (NASDAQ:SAGE) soared more than 20% today after the company announced that the U.S. Food and Drug Administration will allow an expedited development program for one of its most promising drug candidates.

  • [By Shane Hupp]

    SG Americas Securities LLC acquired a new position in SAGE Therapeutics Inc (NASDAQ:SAGE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,233 shares of the biopharmaceutical company’s stock, valued at approximately $843,000.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Hot Medical Stocks To Invest In 2019: Hudson Technologies, Inc.(HDSN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 25 percent to $3.07 after the company reported downbeat Q1 earnings.

    Commodities

  • [By Shane Hupp]

    Hudson Technologies (NASDAQ:HDSN) released its quarterly earnings results on Wednesday. The industrial products company reported ($0.02) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.01 by ($0.03), Bloomberg Earnings reports. Hudson Technologies had a return on equity of 6.44% and a net margin of 1.64%. The business had revenue of $42.43 million during the quarter, compared to the consensus estimate of $45.88 million.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Hudson Technologies (HDSN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Hudson Technologies, Inc. (NASDAQ:HDSN) traded up 20.3% during trading on Thursday following insider buying activity. The company traded as high as $2.73 and last traded at $2.61. 2,803,817 shares changed hands during mid-day trading, an increase of 473% from the average session volume of 488,999 shares. The stock had previously closed at $2.17.

  • [By Lisa Levin]

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 29 percent to $2.9199 after the company reported downbeat Q1 earnings.

    Commodities

Hot Medical Stocks To Invest In 2019: The Rubicon Project, Inc.(RUBI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Rubicon Project (NYSE: RUBI) is one of 44 publicly-traded companies in the “Computer programming, data processing, & other computer related” industry, but how does it weigh in compared to its competitors? We will compare Rubicon Project to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

  • [By Max Byerly]

    Rubicon Project (NYSE:RUBI) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

  • [By Ethan Ryder]

    The Rubicon Project Inc (NYSE:RUBI) saw unusually-high trading volume on Wednesday . Approximately 1,541,600 shares traded hands during trading, an increase of 150% from the previous session’s volume of 615,518 shares.The stock last traded at $3.22 and had previously closed at $2.90.

Hot Medical Stocks To Invest In 2019: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    FibroGen (NASDAQ:FGEN) Director Jorma Routti sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $47.10, for a total transaction of $282,600.00. Following the completion of the transaction, the director now directly owns 133,840 shares in the company, valued at approximately $6,303,864. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on FibroGen (FGEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Insurance Stocks To Own For 2018

7 Facts About the Trump Team’s New Association Health Plan Proposal

7 Facts About the Trump Team’s New Association Health Plan Proposal

5 Questions to Boost Your 2018 Life Insurance Sales

Genworth Financial Inc. believes it has a better chance than some other recent applicants at getting a deal approved by a secretive national security review agency, the Committee on Foreign Investment in the United States (CFIUS).

“We are encouraged by the progress we are making,” Genworth President Tom McInerney said in a statement about the CFIUS clearance process.

Genworth included McInerney’s statement in a CFIUS clearance status update it released Thursday.

(Related: Cyber Risks and CFIUS: A Conversation With MoFo’s John Carlin)

China Oceanwide Holdings Group Co. has been trying to acquire the Richmond, Virginia-based insurer since October 2016.

Genworth has been a major issuer of life insurance, annuities and long-term care insurance. The company is also a major player in the mortgage insurance market.

Best Insurance Stocks To Own For 2018: German American Bancorp, Inc.(GABC)

Advisors’ Opinion:

  • [By Logan Wallace]

    German American Bancorp, Inc. (NASDAQ:GABC) – Research analysts at FIG Partners increased their FY2018 earnings estimates for German American Bancorp in a research report issued to clients and investors on Wednesday, May 2nd. FIG Partners analyst B. Martin now anticipates that the bank will post earnings of $2.02 per share for the year, up from their prior estimate of $2.00.

Best Insurance Stocks To Own For 2018: PennantPark Investment Corporation(PNNT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on PennantPark Investment (PNNT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Insurance Stocks To Own For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top Undervalued Stocks To Own Right Now

NEW YORK The outspoken CEO of the largest automotive dealership chain in the U.S. publicly questioned the market value of Tesla on Tuesday, escalating the rivalry between traditional dealers and the electric-vehicle maker.

Tesla is “either one of the great Ponzi schemes of all time or its gonna work out,” AutoNation CEO Mike Jackson said at a forum presented ahead of theahead of the New York Auto Show by the National Automobile Dealers Association and consultantstheJ.D.Power.

His comments came a day after Tesla briefly passed General Motors as the most valuable American automaker, as measured by market capitalization.

“ClearlyGeneral Motors is undervalued and Tesla is overvalued,” Jackson said. “Anybody can see that.”

The typically brash CEO’s remarks came amid a stock rally for Tesla, which is riding high amid signs that its mass-market Model 3 electric car may be on track to begin sales in 2017.

Top Undervalued Stocks To Own Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

Top Undervalued Stocks To Own Right Now: Best Buy Co., Inc.(BBY)

Advisors’ Opinion:

  • [By ]

    The reluctance of millennials to spend their tax cuts could hurt the stock prices of many consumer companies. Shares of department stores such as Kohl’s (KSS) and an electronics retailer like Best Buy (BBY) have run up this year on expectations of consumers shopping till they drop this spring/summer. Considering there are more than 83 million millennials in the U.S., that’s a big pool of humans letting down some of the country’s biggest companies. 

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Best Buy Co., Inc. (NYSE: BBY) which traded down over 3% at $55.33. The stocks 52-week range is $41.67 to $63.32. Volume was18 million versus the daily average of 4.7 million shares.

  • [By Leo Sun]

    But on April 19, Roku’s stock plunged 12% after Amazon partnered with Best Buy (NYSE:BBY) to sell new Amazon-powered “Fire TVs” in its stores and on its website this summer. These TVs — which are produced by Toshiba and Best Buy’s in-house brand Insignia — will be fully integrated with Amazon’s services andAlexa. Best Buy will also become a merchant for the Fire TVs on Amazon’s website.

  • [By Lisa Levin]

    Best Buy Co Inc (NYSE: BBY) reported better-than-expected earnings for its fourth quarter, but sales missed estimates. The company also issued weak earnings forecast for the current quarter.

  • [By WWW.THESTREET.COM]

    Shares of Best Buy (BBY)  are again going haywire after the company’s earnings report, as a combination of low Wall Street expectations and clever tactics by the company’s executives drummed up another decent quarter and outlook. 

  • [By The Ticker Tape]

    Retailers Take Center Stage: It’s “Black Friday,” meaning attention might turn to retailers like Wal-Mart Stores, Inc. (NYSE: WMT), Best Buy Co Inc (NYSE: BBY), Amazon.com, Inc. (NASDAQ: AMZN), and Target Corporation (NYSE: TGT), among others. Retail sales kicked up in October, and Halloween sales also looked pretty solid, which could point toward a strong winter holiday shopping season. Job growth has also been relatively healthy of late, another factor that could play into holiday sales. Jobless claims stayed below 300,000 last week for the 90th-consecutive week, the longest stretch in more than 45 years. We’ll get further insight on the jobs climate at the end of next week when November Non-farm payrolls data roll in, and that could provide more clues as to just how well-equipped consumers might be for those shopping expeditions.

Top Undervalued Stocks To Own Right Now: First Horizon National Corporation(FHN)

Advisors’ Opinion:

  • [By ]

    In this environment, investors should be looking to add the banks to their portfolios. He likes Goldman Sachs (GS) and First Horizon National (FHN) , which appeared on “Mad Money” last week. He would avoid any high-yielding stock however, as they are getting increased competition from risk-free Treasuries.

  • [By ]

    In an “Executive Decision” segment, Cramer sat down with Bryan Jordan, chairman, president and CEO of First Horizon National (FHN) , the Tennessee-based regional bank that just posted a three-cents-a-share earnings beat with net interest margins up 52 basis points.

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

  • [By ]

    In his second “Executive Decision” segment, Cramer also sat down with Bryan Jordan, chairman, president and CEO of First Horizon National (FHN) , the Tennessee-based regional bank that just posted a three-cents-a-share earnings beat with net interest margins up 52 basis points.

Hot Clean Energy Stocks To Invest In 2018

Related CLNE 20 Biggest Mid-Day Losers For Friday Mid-Day Market Update: ConforMIS Gains Following Strong Q3 Results; MDC Partners Shares Drop Clean Energy Fuels Corp. – Bridge Funding For A Bridge Fuel (Seeking Alpha)
Related FRO Earnings Scheduled For November 29, 2016 Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Misses Estimates Frontline's (FRO) CEO Robert McLeod on Q3 2016 Results – Earnings Call Transcript (Seeking Alpha)

 

Toward the end of trading Wednesday, the Dow traded down 0.35 percent to 18,388.83 while the NASDAQ declined 0.25 percent to 5,209.89. The S&P also fell, dropping 0.36 percent to 2,168.24.

Leading and Lagging Sectors

Wednesday afternoon, non-cyclical consumer goods & services shares gained by 0.10 percent..

In trading on Wednesday, energy shares fell by 1.72 percent. Meanwhile, top losers in the sector included Clean Energy Fuels Corp (NASDAQ: CLNE), down 5 percent, and Frontline Ltd. (NYSE: FRO), down 7 percent.

Hot Clean Energy Stocks To Invest In 2018: Watts Water Technologies, Inc.(WTS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

  • [By Stephan Byrd]

    A number of institutional investors and hedge funds have recently made changes to their positions in WTS. SeaCrest Wealth Management LLC acquired a new position in Watts Water Technologies during the fourth quarter worth about $112,000. Xact Kapitalforvaltning AB acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $224,000. Sawgrass Asset Management LLC acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $270,000. Koch Industries Inc. raised its position in shares of Watts Water Technologies by 22.0% in the fourth quarter. Koch Industries Inc. now owns 3,821 shares of the technology company’s stock valued at $290,000 after buying an additional 690 shares during the last quarter. Finally, Quadrature Capital Ltd acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $330,000. Institutional investors own 77.22% of the company’s stock.

    ILLEGAL ACTIVITY NOTICE: “Watts Water Technologies (WTS) Expected to Post Quarterly Sales of $362.52 Million” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/3380368/watts-water-technologies-wts-expected-to-post-quarterly-sales-of-362-52-million.html.

    Watts Water Technologies Company Profile

Hot Clean Energy Stocks To Invest In 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

Hot Clean Energy Stocks To Invest In 2018: SK TELECOM ADR EACH REP 1/9 KRW500(CIT)

Advisors’ Opinion:

  • [By Lisa Abramowicz]

    There was this maturity wall that people were terrified of, said Neil Wessan, the group head of New York-based CIT Group Inc. (CIT)s capital markets unit. Thats been spread out over a much broader period of time.

  • [By Ben Levisohn]

    We will admit that these latter assumptions are somewhat arbitrary, but nevertheless we cannot help escape the view that in 2017 everything will likely be at least a little adverse to prior expectations. On average our estimate reductions are 8%, and range from 3% at CIT Group (CIT) to 13% at Goldman Sachs. With that, we are lowering our PT of Bank of America,Citigroup andGoldman Sachs from $20, $70 and $243 to $18, $63 and $214, respectively…

Hot Clean Energy Stocks To Invest In 2018: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cellectis SA (ADR) (NASDAQ: CLLS) shares dropped 20 percent to $25.70 after announcing FDA clinical hold of UCART123 studies.

    Shares of Opiant Pharmaceuticals Inc (NASDAQ: OPNT) were down 10 percent to $35.20. Opiant Pharma named David O'Toole as CFO.

  • [By Jim Robertson]

    Yesterday, small cap clinical-stage biopharmaceutical stock Cellectis SA (NASDAQ: CLLS) reported that they had received notice fromFDA that a clinical hold was placed on both UCART123 ongoing Phase 1 studies -in acute myeloid leukemia (AML) and in blastic plasmacytoid dendritic cell neoplasm (BPDCN). The clinical hold was initiated after Cellectis reported one fatality in the BPDCN clinical trial (ABC study) with the Company now working closelywith the investigators and the FDA in order to resume the trials with an amended protocol including a lowered dosing of UCART123. The FDA has a detailed page about clinical holds which mentions:

Hot Clean Energy Stocks To Invest In 2018: PHI, Inc.(PHIIK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap offshore oil and gas services stock PHI Inc (NASDAQ: PHIIK):

    We’re a little bit late to the party here, but that’s ok – there’s still some meat left on the bone, so to speak. Were looking for the stock to continue on to the lower edge of a long-term (and bearish) trading range that should allow it to peel back to at least the lower $12’s. We’ve see PHIIK shares tumble with great speed and distance a couple of times already, and we’re about halfway through round three.

good stocks to invest in now

As Texas considers a “bathroom bill” aimed at transgender individuals, top executives have sent a clear message to the state’s governor: We oppose it.

On Monday, more than 50 business leaders from the Houston area sent a letter to Gov. Greg Abbott, a Republican, asking him to “avoid any actions, including the passage of any ‘bathroom bill,’ that would threaten our continued growth.”

Executives who signed on include the chairman and president of BP America, the CEO of Halliburton (HAL), the CEO of ConocoPhillips (COP), the president of Shell Oil Company and the president of ExxonMobil Global Services Company, a division of ExxonMobil (XOM).

“We support diversity and inclusion, and we believe that any such bill risks harming Texas’ reputation and impacting the state’s economic growth and ability to create new jobs,” the letter reads.

Dallas business leaders sent a similar letter protesting the proposed state law to Abbott earlier this month. That one was signed by Doug Parker, the CEO of American Airlines (AAL), Randall Stephenson, the CEO of AT&T (T, Tech30), and Gary Kelly, the CEO of Southwest Airlines (LUV). (AT&T has agreed to acquire Time Warner, the parent company of CNN. The deal is pending regulatory approval.)

good stocks to invest in now: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

good stocks to invest in now: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Humana Inc. (NYSE: HUM) which rose over 4% to $280.36. The stocks 52-week range is $206.68 to $293.35. Volume was 3.2 million compared to the daily average volume of 1.1 million.

  • [By Paul Ausick]

    Late Thursday, reports began to trickle in that retail behemoth Walmart Inc. (NYSE: WMT) was in preliminary negotiations to acquire health insurer Humana Inc. (NYSE: HUM). Humana’s market cap of around $37 billion makes this a very big deal, even if the talks result in some sort of partnership between the two firms.

  • [By ]

    The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Keith Speights]

    Although Aetna wasn’t successful in its attempted merger with Humana (NYSE:HUM), the blocked deal shouldn’t have too much residual effect. Aetna’s share price remains attractively valued, currently trading at 13 times expected earnings.

  • [By Lisa Levin]

    Humana Inc (NYSE: HUM) delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.

good stocks to invest in now: The Bon-Ton Stores, Inc.(BONT)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Lastly, there are a few department-store chains that have been struggling mightily. Sears tops the list, of course. Bon-Ton Stores (NASDAQ:BONT) and Neiman Marcus are also in serious trouble. All three chains have too much debt and have been reporting some of the worst sales results in the industry.

  • [By Peter Graham]

    The Q3 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Thursday (November 17th) as traditional department stores continue to struggle to figure out how to attract costumers into their stores as online giants increasingly become thedominant retail players.

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT) reported Q2 2017 earnings before the market opened on Thursday while earnings guidance for the full year fiscal 2017 was reaffirmed. Total sales decreased 7.0% to $504.4 million as comparable store sales decreased 6.1% versus the prior year period. However,double-digit sales growth continued in the omnichannel, which reflects sales via the Company’s website, mobile site, and its Let Us Find It customer service program, as the Company leveraged its West Jefferson facility and store-fulfillment network. The net loss was $33.2 million versus a net loss of $38.7 million.The CEO commented:

  • [By Paul Ausick]

    The Bon-Ton Stores Inc. (NASDAQ: BONT) dropped about 3.3% Thursday to post a new 52-week low of $0.31 after closing Wednesday at $0.32. The 52-week high is $1.98. Volume was around 10 million shares traded, about 100 times the daily average of around 100,000. The struggling retailer had no specific news.

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)reported fiscalQ1 earnings before the market opened this morning with total salesdown 9.3% to $536.1 million and comparable store sales down 8.8%. Theearnings release noted:

  • [By Adam Levine-Weinberg]

    Not long ago, liquidation seemed inevitable for bankrupt department store operator Bon-Ton Stores Inc. (NASDAQ:BONT). The company’s desperate attempt to restructure outside the bankruptcy process failed earlier this year when it couldn’t find an investor willing to finance a comeback effort.

good stocks to invest in now: Methanex Corporation(MEOH)

Advisors’ Opinion:

  • [By Jim Robertson]

    Back in February of last year, we suggested Methanex Corporation (MEOH), which ended up providing us with some pretty good gains in a fairly short amount of time, and based on what’s happening with the stock technically right now, it could be another gainer over the next several days to few weeks.

good stocks to invest in now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.